Sangamo Therapeutics share price today

(SGMO)

Sangamo Therapeutics share price is $2.47 & ₹209.89 as on 21 Dec 2024, 2.30 'hrs' IST

$2.47

▲

0.16

(6.93%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Sangamo Therapeutics share price in Dollar and Rupees. Guide to invest in Sangamo Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Sangamo Therapeutics. Get details on the Indian mutual funds that are investing in Sangamo Therapeutics. Get Analyst recommendations and forecasts along with all the Sangamo Therapeutics's financials.

Sangamo Therapeutics share price movements

Today's Low: $2.28
Today's High: $2.53
$2.47
7.69%
Downside
Day's Volatility :9.81%
Upside
2.29%
52 Weeks Low: $0.30
52 Weeks High: $3.18
$2.47
87.69%
Downside
52 Weeks Volatility :90.44%
Upside
22.3%

Sangamo Therapeutics Returns

Period	Sangamo Therapeutics, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	169.95%	-11.1%	0.0%
6 Months	425.76%	-6.0%	0.0%
1 Year	487.54%	2.7%	0.0%
3 Years	-70.49%	0.6%	-19.7%

Sangamo Therapeutics Key Statistics

in dollars & INR

Previous Close	$2.31
Open	$2.3
Today's High	$2.5279
Today's Low	$2.28
Market Capitalization	$563.2M
Today's Volume	$13.5M
52 Week High	$3.179
52 Week Low	$0.304
Revenue TTM	$12.3M
EBITDA	$-185.0M
Earnings Per Share (EPS)	$-1.24
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-194.05%

How to invest in Sangamo Therapeutics from India?

It is very easy for Indian residents to invest directly in Sangamo Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sangamo Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sangamo Therapeutics or SGMO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sangamo Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sangamo Therapeutics shares which would translate to 0.344 fractional shares of Sangamo Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Sangamo Therapeutics, in just a few clicks!

Returns in Sangamo Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Sangamo Therapeutics investment value today

Current value as on today

₹5,90,291

Returns

₹4,90,291

(+490.29%)

Returns from Sangamo Therapeutics Stock

₹4,88,095 (+488.1%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Sangamo Therapeutics

-52%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Sangamo Therapeutics on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -52% less investors are searching Sangamo Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Sangamo Therapeutics

Wasatch Advisors LP
9.32%
Vanguard Group Inc
4.60%
Renaissance Technologies Corp
2.33%
BlackRock Inc
2.25%
Marshall Wace Asset Management Ltd
1.13%
Geode Capital Management, LLC
1.02%

Analyst Recommendation on Sangamo Therapeutics

Buy

66%Buy

33%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Sangamo Therapeutics(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Sangamo Therapeutics

What analysts predicted

Upside of 94.33%

Current:

$2.47

Target:

$4.80

Insights on Sangamo Therapeutics

Price Movement
In the last 6 months, SGMO stock has moved up by 455.3%
Increasing Revenue
Revenue is up for the last 2 quarters, 356.0K → 49.41M (in $), with an average increase of 99.3% per quarter
Increasing Net Profit
Netprofit is up for the last 6 quarters, -114.50M → 10.67M (in $), with an average increase of 116.0% per quarter
SGMO vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 93.2%

Sangamo Therapeutics Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$84.5M	↑ 130.95%
Net Income	$-68.3M	↑ 25.23%
Net Profit Margin	-80.91%	↑ 68.32%

	FY19	Y/Y Change
Revenue	$102.4M	↑ 21.29%
Net Income	$-75.8M	↑ 10.95%
Net Profit Margin	-74.02%	↑ 6.89%

	FY20	Y/Y Change
Revenue	$118.2M	↑ 15.39%
Net Income	$-121.1M	↑ 59.75%
Net Profit Margin	-102.48%	↓ 28.46%

	FY21	Y/Y Change
Revenue	$110.7M	↓ 6.34%
Net Income	$-178.3M	↑ 47.2%
Net Profit Margin	-161.06%	↓ 58.58%

	FY22	Y/Y Change
Revenue	$111.3M	↑ 0.54%
Net Income	$-192.3M	↑ 7.84%
Net Profit Margin	-172.76%	↓ 11.7%

	FY23	Y/Y Change
Revenue	$176.2M	↑ 58.34%
Net Income	$-257.8M	↑ 34.09%
Net Profit Margin	-146.3%	↑ 26.46%

	Q2 FY23	Q/Q Change
Revenue	$6.8M	↓ 95.67%
Net Income	$-114.5M	↓ 641.84%
Net Profit Margin	-1.7K%	↓ 1688.67%

	Q3 FY23	Q/Q Change
Revenue	$9.4M	↑ 37.5%
Net Income	$-104.2M	↓ 9.03%
Net Profit Margin	-1.1K%	↑ 566.94%

	Q4 FY23	Q/Q Change
Revenue	$2.0M	↓ 78.27%
Net Income	$-60.3M	↓ 42.11%
Net Profit Margin	-3.0K%	↓ 1844.44%

	Q1 FY24	Q/Q Change
Revenue	$481.0K	↓ 76.44%
Net Income	$-49.1M	↓ 18.59%
Net Profit Margin	-10.2K%	↓ 7252.82%

	Q2 FY24	Q/Q Change
Revenue	$356.0K	↓ 25.99%
Net Income	$-36.1M	↓ 26.4%
Net Profit Margin	-10.1K%	↑ 57.3%

	Q3 FY24	Q/Q Change
Revenue	$49.4M	↑ 13779.78%
Net Income	$10.7M	↓ 129.54%
Net Profit Margin	21.6%	↑ 10169.91%

	FY18	Y/Y Change
Profit	$84.5M	↑ 130.95%

	FY19	Y/Y Change
Profit	$102.4M	↑ 21.29%

	FY20	Y/Y Change
Profit	$118.2M	↑ 15.39%

	FY21	Y/Y Change
Profit	$110.7M	↓ 6.34%

	FY22	Y/Y Change
Profit	$111.3M	↑ 0.54%

	FY23	Y/Y Change
Profit	$-45.3M	↓ 140.72%

	Q2 FY23	Q/Q Change
Profit	$2.6M	↓ 98.33%

	Q3 FY23	Q/Q Change
Profit	$-113.0K	↓ 104.38%

	Q4 FY23	Q/Q Change
Profit	$-940.0K	↑ 731.86%

	Q1 FY24	Q/Q Change
Profit	$-2.0M	↑ 117.55%

	Q2 FY24	Q/Q Change
Profit	$-2.2M	↑ 8.41%

	Q3 FY24	Q/Q Change
Profit	$49.4M	↓ 2328.78%

	FY18	Y/Y Change
Operating Cash Flow	$37.2M	↑ 232.34%
Investing Cash Flow	$-178.1M	↑ 120.14%
Financing Cash Flow	$231.7M	↑ 137.67%

	FY19	Y/Y Change
Operating Cash Flow	$-144.4M	↓ 488.68%
Investing Cash Flow	$-59.8M	↓ 66.42%
Financing Cash Flow	$142.0M	↓ 38.7%

	FY20	Y/Y Change
Operating Cash Flow	$169.9M	↓ 217.64%
Investing Cash Flow	$-271.6M	↑ 354.22%
Financing Cash Flow	$153.1M	↑ 7.79%

	FY21	Y/Y Change
Operating Cash Flow	$-233.3M	↓ 237.31%
Investing Cash Flow	$248.2M	↓ 191.37%
Financing Cash Flow	$32.9M	↓ 78.54%

	FY22	Y/Y Change
Operating Cash Flow	$-223.6M	↓ 4.13%
Investing Cash Flow	$59.3M	↓ 76.11%
Financing Cash Flow	$84.7M	↑ 157.65%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-60.7M	↓ 8.43%
Investing Cash Flow	$42.5M	↑ 18.86%
Financing Cash Flow	$6.5M	↓ 18.53%

Sangamo Therapeutics Technicals Summary

Sell

Neutral

Buy

Sangamo Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Sangamo Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Sangamo Therapeutics, Inc.	26.02%	425.76%	487.54%	-70.49%	-76.94%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Sangamo Therapeutics, Inc.	NA	NA	0.0	-0.48	-1.94	-0.58	NA	0.47
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Sangamo Therapeutics, Inc.	Buy	$563.2M	-76.94%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Sangamo Therapeutics

for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.

Organization	Sangamo Therapeutics
Employees	405
CEO	Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.
Industry	Health Technology

Management People of Sangamo Therapeutics

Name	Title
Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.	CEO, President & Director
Ms. Prathyusha Duraibabu CPA, M.B.A.	Senior VP, CFO & Principal Accounting Officer
Dr. Nathalie Dubois-Stringfellow Ph.D.	Senior VP & Chief Development Officer
Mr. Gregory Davis Ph.D.	Head of Research & Technology
Ms. Aron Feingold	Head of Corporate Communications & Investor Relations Officer
Mr. Scott B. Willoughby	Senior VP, General Counsel & Corporate Secretary
Mr. Phillip Ramsey	Head of Technical Operations
Ms. Stephanie J. Seiler CLP	Head of Business Development & Alliance Management
Mr. David Ojala	Scientist II - Discovery & Translational Research
Ms. Louise Wilkie	Vice President of Investor Relations & Corporate Communications

Important FAQs about investing in Sangamo Therapeutics from India :

What is Sangamo Therapeutics share price today?

Sangamo Therapeutics share price today stands at $2.47, Open: $2.30 ; Previous Close: $2.31 ; High: $2.53 ; Low: $2.28 ; 52 Week High: $3.18 ; 52 Week Low: $0.30. The stock opens at $2.30, after a previous close of $2.31. The stock reached a daily high of $2.53 and a low of $2.28, with a 52-week high of $3.18 and a 52-week low of $0.30.

Can Indians buy Sangamo Therapeutics shares?

Yes, Indians can invest in the Sangamo Therapeutics (SGMO) from India.

With INDmoney, you can buy Sangamo Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Sangamo Therapeutics at zero transaction cost.

How can I buy Sangamo Therapeutics shares from India?

It is very easy to buy Sangamo Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sangamo Therapeutics be purchased?

Yes, you can buy fractional shares of Sangamo Therapeutics with INDmoney app.

What are the documents required to start investing in Sangamo Therapeutics stocks?

To start investing in Sangamo Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.